Trials / Completed
CompletedNCT00586378
Ovatio DR and VR Implantable Cardioverter Defibrillators Post-approval Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- ELA Medical, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this post-approval study is to confirm the safety and effectiveness of Ovatio DR and VR ICDs
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ovatio DR and Ovatio VR | implantable cardioverter defibrillator |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2008-01-04
- Last updated
- 2012-03-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00586378. Inclusion in this directory is not an endorsement.